Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (261-270 of 358) with videos related to

Pageof 36
Sort By:
Journal of Global Antimicrobial Resistance|June 18, 2019
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?Silvia Corcione, Antonio D'Avolio, Riccardo Corgiat Loia, et al.
AIDS Research and Human Retroviruses|August 17, 2004
The relationship between nevirapine plasma concentrations and abnormal liver function testsLisa M Almond, Marta Boffito, Patrick G Hoggard, et al.
Cancer|November 25, 2003
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcomaGuglielmo Nasti, Ferdinando Martellotta, Massimiliano Berretta, et al.
Current HIV Research|September 30, 2015
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and PharmacokineticsAndrea Calcagno, Chiara Montrucchio, Amedeo Capetti, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 20, 2012
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patientsAntonio D'Avolio, Amedeo De Nicolò, Marco Simiele, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 2014
Combination of conventional blood cultures and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogensElisa Burdino, Tina Ruggiero, Tiziano Allice, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapyJessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2010
Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscessesMassimo Arlotti, Paolo Grossi, Federico Pea, et al.
Infection|November 4, 2017
Current and future challenges in HCV: insights from an Italian experts panelMassimo Andreoni, Sergio Babudieri, Savino Bruno, et al.
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Pageof 36

Showing results (261-270 of 358) with videos related to

Sort By:
Pageof 36
Journal of Global Antimicrobial Resistance|June 18, 2019
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?Silvia Corcione, Antonio D'Avolio, Riccardo Corgiat Loia, et al.
AIDS Research and Human Retroviruses|August 17, 2004
The relationship between nevirapine plasma concentrations and abnormal liver function testsLisa M Almond, Marta Boffito, Patrick G Hoggard, et al.
Cancer|November 25, 2003
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcomaGuglielmo Nasti, Ferdinando Martellotta, Massimiliano Berretta, et al.
Current HIV Research|September 30, 2015
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and PharmacokineticsAndrea Calcagno, Chiara Montrucchio, Amedeo Capetti, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 20, 2012
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patientsAntonio D'Avolio, Amedeo De Nicolò, Marco Simiele, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 2014
Combination of conventional blood cultures and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogensElisa Burdino, Tina Ruggiero, Tiziano Allice, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2015
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapyJessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2010
Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscessesMassimo Arlotti, Paolo Grossi, Federico Pea, et al.
Infection|November 4, 2017
Current and future challenges in HCV: insights from an Italian experts panelMassimo Andreoni, Sergio Babudieri, Savino Bruno, et al.
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Pageof 36